Materias dentro de su búsqueda.
Mostrando 101 - 120 Resultados de 1,366 Para Buscar '"Leiden"', tiempo de consulta: 0.17s Limitar resultados
  1. 101
    por Kreidy, Raghid
    Publicado 2012
    “…Lebanon exhibits one of the highest prevalences of factor V-Leiden (FVL) in the world (14.4%). The aim of this study is to evaluate the incidence of FVL mutation among Lebanese patients with lower extremity venous thrombosis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Factor V-Leiden Mutation: A Common Risk Factor for Venous Thrombosis among Lebanese Patients
  2. 102
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus Study
  3. 103
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Reference values for generic instruments used in routine outcome monitoring: the leiden routine outcome monitoring study
  4. 104
    “…RESULTS: 378 persons aged 88 years participating to the Leiden 85 plus study, an observational prospective cohort study in the general population, were included. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prediction of mortality and functional decline by changes in eGFR in the very elderly: the Leiden 85-plus study
  5. 105
    “…Hormonal changes during pregnancy and the puerperium carry an increased risk of venous thromboembolism including cerebral venous sinus thrombosis (CVST). Factor 5 leiden (FVL) is a procoagulant mutation associated primarily with venous thrombosis and pregnancy complications. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    HELLP Syndrome and Cerebral Venous Sinus Thrombosis Associated with Factor V Leiden Mutation during Pregnancy
  6. 106
    “…Hematologic workup also discovered a factor V Leiden mutation, further predisposing the patient to DVT. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Congenital anomaly of the inferior vena cava and factor V Leiden mutation predisposing to deep vein thrombosis
  7. 107
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Thrombotic microangiopathy associated with sunitinib, a VEGF inhibitor, in a patient with factor V Leiden mutation
  8. 108
    “…BACKGROUND: Factor V Leiden, Prothrombin and MTHFR gene mutation, could have an influence in pregnancy with adverse outcome Preeclamsia, IUGR and Placental abruption. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Factor V Leiden, Prothrombin and MTHFR Mutation in Patients with Preeclamsia, Intrauterine Growth Restriction and Placental Abruption
  9. 109
    “…Mutational changes, which abolish APC cleavage sites, may predispose thrombosis by altering the inactivation process of FV. FV Leiden (FVL) (Arg506Glu) has been demonstrated as a strong risk factor for thrombosis. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Polymorphisms at activated protein C cleavage sites of factor V: Are they important in the absence of factor V Leiden?
  10. 110
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Butyrate Reduces HFD-Induced Adipocyte Hypertrophy and Metabolic Risk Factors in Obese LDLr-/-.Leiden Mice
  11. 111
    “…BACKGROUND: Cancer and factor V Leiden mutation are both risk factors for venous thromboembolism (VTE). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Risk of venous thromboembolism in association with factor V leiden in cancer patients – The EDITH case-control study
  12. 112
    “…BACKGROUND: Previous results regarding the prevalence of Factor V Leiden (FVL) in patients with cerebral venous thrombosis (CVT) varied remarkably. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevalence and geographical variation of Factor V Leiden in patients with cerebral venous thrombosis: A meta-analysis
  13. 113
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Abstract: Free-Flap Outcomes and Screening Options in Factor V Leiden: A Systematic Literature Review
  14. 114
    “…RATIONALE: Although Factor V Leiden (FVL) mutation is a major cause of inherited thrombophilia in Western populations; the mutation is extremely rare in Asia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Acute pulmonary thromboembolism caused by factor V Leiden mutation in South Korea: A case report
  15. 115
    “…To characterize their effect on atherogenesis, APOE*3Leiden.CETP mice were fed a high cholesterol/high fat diet (WTD) or normal chow (NC) for 18 weeks. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice
  16. 116
    “…METHODS: We assessed outcomes of receiving direct‐to‐consumer (DTC) results for the two most common genetic risk factors for VTE, factor V Leiden in the F5 gene (FVL) and prothrombin 20210G>A in the F2 gene (PT). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Direct‐to‐consumer genetic testing for factor V Leiden and prothrombin 20210G>A: the consumer experience
  17. 117
    “…Coexistent heterozygous factor V Leiden and homozygous prothrombin G20210A gene mutations is a rare and potentially life-threatening occurrence. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Anticoagulation Therapy in a Patient With Heterozygous Factor V Leiden and Coexisting Homozygous Prothrombin Gene Mutations
  18. 118
    “…METHODS: We included 555 participants from the Leiden 85-plus Study, a prospective population-based study of 85-year-old inhabitants of Leiden, the Netherlands. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical determinants of low handgrip strength and its decline in the oldest old: the Leiden 85-plus Study
  19. 119
    “…Biochemical and autoimmune markers were normal, except for Factor V Leiden and methylenetetrahydrofolate reductase enzyme (MTHFR-C677T) heterozygous mutations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Papillophlebitis Associated With Coexisting Heterozygous Mutations of Factor V Leiden and Methylenetetrahydrofolate Reductase Enzyme-(C677T)
  20. 120
    “…We report the case of a 63-year-old patient with a factor V Leiden mutation in whom an aortic arch thrombus was discovered accidentally. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Successful Conservative Treatment of a Complicated Aortic Thrombus in a Woman with Factor V Leiden Mutation
Herramientas de búsqueda: RSS